Almirall and IRB Barcelona team up to tackle skin disease
pharmaphorum
JANUARY 18, 2022
Almirall and IRB Barcelona (the Institute for Research in Biomedicine), will conduct research using molecular glue degraders, a new approach to the skin diseases under scrutiny. This is where molecular glue degraders come in. It also builds on complementary core expertise of each partner to facilitate research and drug development.”.
Let's personalize your content